<DOC>
<DOCNO>EP-0659177</DOCNO> 
<TEXT>
<INVENTION-TITLE>
4-OXO-AZETIDINE-2-SULPHONIC ACID AMIDES AND THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND THEIR USE
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31397	A61K31395	A61P3100	A61K31397	A61P3104	A61K31395	C07D20509	C07D40312	C07D41312	C07D41314	C07D40300	C07D20500	C07D205095	C07D41300	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61K	A61P	A61K	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P31	A61K31	A61P31	A61K31	C07D205	C07D403	C07D413	C07D413	C07D403	C07D205	C07D205	C07D413	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
4-oxo-azetidine-2-sulphonic acid amides and their salts of general formula (I) in which the residues have the following meanings: R1: hydrogen, halogen; R2: hydrogen, halogen, NH2, phenyl-CH2CONH, phenylOCH2CONH, phthalimido, o-MeNHCOC6H4CONH, isoxazolyl carbonyl amino; R3: hydrogen, Me2C=C-COOMe, H2C=C(Me)-CH-COOMe, Me2C=C-COOCH2 phenyl, H2C=C(me)-CH-COOCH2C6H4NO2-p, Me2C=C-COOCH2C6H4NO2-p Me2C=C-COOCH2C6H4NO2-m, H2C=C(Me)-CHCO-OCH2C6H4Me-m, ME2C=C-COOH; R4: hydrogen or sodium; and R5: hydrogen, alkyl, benzyl or a heterocycle, e.g. isoxazole, pyrazole, etc.; process for their production and their use as intermediate compounds for the synthesis of beta-lactame analogues or as agents in the production of preparation for antimicrobial therapy.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
4-oxo-azetidine-2-sulfonic acid amides and their salts of the general formula I


in which the groups are defined as follows:

R
1
 represents hydrogen, halogen:
R
2
 represents hydrogen, halogen, NH
2
, phenyl-CH
2
CONH, phenyl-OCH
2
CONH.
phthalimido, o-MeNHCOC
6
H
4
CONH, isoxazolylcarbonylamino;
R
3
 represents hydrogen, Me
2
C=C-COOMe, H
2
C=C(Me)-CH-COOMe,
Me
2
C=C-COOCH
2
phenyl, H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
NO
2
-p,
Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p, Me
2
C=C-COOCH
2
C
6
H
4
Me-m,
H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
Me-m, Me
2
C=C-COOH;
R
4
 represents hydrogen or sodium and
R
5
 represents alkyl, benzyl, isoxazole or pyrazole.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen.
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
sodium and R
5
 represents phenyl-CH
2
. 
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents hydrogen, R
4
 represents hydrogen and R
5

represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents bromine,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
Phenyl, R
4
 represents
hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents bromine, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents bromine,
R
2
 represents bromine, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents bromine,
R
2
 represents bromine, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
sodium and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
sodium and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents bromine.
R
2
 represents bromine, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl. 
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents 3,4-dimethyl-isoxazol-5-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
sodium and R
5
 represents 3,4-dimethyl-isoxazol-5-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
hydrogen and R
5
 represents 2-phenyl-pyrazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOCH
2
phenyl, R
4
 represents
sodium and R
5
 represents 2-phenyl-pyrazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-OCH
2
CONH, R
3
 represents Me
2
C=C-COOMe,
R
4
 represents hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen.
R
2
 represents phenyl-OCH
2
CONH, R
3
 represents H
2
C=C(Me)CH-COOMe,
R
4
 represents hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-OCH
2
CONH, R
3
 represents Me
2
C=C-COOMe,
R
4
 represents hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phthalimido, R
3
 represents H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 rcpresents 5-methyl-isoxazol-3-yl. 
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phthalimido, R
3
 represents Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents hydrogen, R
4
 represents hydrogen
and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOH, R
4
 represents
hydrogen and R
5
 represents methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOH, R
4
 represents hydrogen
and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents 3-o-chlorophenyl-5-methyl-isoxazol-4-yl, R
3
 represents
H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
Me-m, R
4
 represents hydrogen and R
5
 represents
5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents 3-o-chlorophenyl-5-methyl-isoxazol-4-yl, R
3
 represents
Me
2
C=C-COOCH
2
C
6
H
4
Me-m, R
4
 represents hydrogen and R
5
 represents
5-methyl-isoxazol-3-yl. 
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phthalimido, R
3
 represents Me
2
C=C-COOH, R
4
 represents hydrogen
and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents amino, R
3
 represents Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p, R
4
 represents
hydrogen and R
5
 represents 5-methyl-isoxazol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents o-MeNHCOC
6
H
4
CONH, R
3
 represents Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 represents methyl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents o-MeNHCOC
6
H
4
CONH, R
3
 represents H
2
C=C(Me)-CH-COOCH
2
-C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 represents methyl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents o-MeNHCOC
6
H
4
CONH, R
3
 represents Me
2
C=C-COOH,
R
4
 represents hydrogen and R
5
 represents methyl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOH, R
4
 represents
hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOCH
2
-C
6
H
4
NO
2
-p,
R
4
 represents hydrogen and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOCH
2
-C
6
H
4
NO
2
-p.
R
4
 represents hydrogen and R
5
 represents methyl. 
A compound according to Claim 1, characterised in that R
1
 represents hydrogen,
R
2
 represents phenyl-CH
2
CONH, R
3
 represents Me
2
C=C-COOH, R
4
 represents
hydrogen and R
5
 represents methyl.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen.
R
2
 represents hydrogen, R
3
 represents Me
2
C=C-COOH, R
4
 represents hydrogen
and R
5
 represents 5-methyl-isoxasol-3-yl.
A compound according to Claim 1, characterised in that R
1
 represents bromine.
R
2
 represents bromine, R
3
 represents Me
2
C=C-COOH, R
4
 represents hydrogen
and R
5
 represents phenyl-CH
2
.
A compound according to Claim 1, characterised in that R
1
 represents hydrogen.
R
2
 represents phenyl-OCH
2
CONH, R
3
 represents Me
2
C=C-COOH, R
4
 represents
hydrogen and R
5
 represents 5-methyl-isoxasol-3-yl.
A process for preparing 4-oxo-azetidine-2-sulfonic acid amides and their salts of
the general formula I, in which the groups are defined in the same way as in Claim

1, characterised in that 4-oxo-azetidine-2-sulfinic acid amides of the general
formula II



in which the groups are defined as follows:

R
1
 represents hydrogen or halogen;
R
2
 represents hydrogen, halogen, phenyl-CH
2
CONH, phenyl-OCH
2
CONH,
phthalimido, o-MeNHCOC
6
H
4
CONH, isoxazolylcarbonylamino; 
R
3
 represents Me
2
C=C-COOMe, H
2
C=C(Me)-CH-COOMe,
Me
2
C=C-COOCH
2
phenyl, H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
NO
2
-p,
Me
2
C=C-COOCH
2
C
6
H
4
NO
2
-p, Me
2
C=C-COOCH
2
C
6
H
4
Me-m,
H
2
C=C(Me)-CH-COOCH
2
C
6
H
4
Me-m;
R
4
 represents hydrogen and
R
5
 represents alkyl, benzyl, isoxazole or pyrazole

are oxidised in agents conventionally recognised for oxidations in organic
chemistry such as e.g. hydrogen peroxide, peracetic acid, m-chlorobenzoic acid

and potassium permanganate, in an acid or neutral, aqueous or aqueous/organic

medium and at a temperature of 0 to 100°C, then the protective groups are
removed, the reaction mixture processed and the product isolated in a

conventional manner.
Use of the compound according to Claim 1 as an intermediate compound for the
synthesis of beta-lactam analogues, in particular bicyclic systems.
Use of the compound according to Claim 1 as an active ingredient for producing
preparations for antimicrobial treatment.
</CLAIMS>
</TEXT>
</DOC>
